McKesson Corporation (BVMF:M1CK34)

Market Cap	559.37B
Revenue (ttm)	2.06T
Net Income (ttm)	21.49B
Shares Out	n/a
EPS (ttm)	171.17
PE Ratio	26.02
Forward PE	20.69
Dividend	2.83 (0.25%)
Ex-Dividend Date	Nov 28, 2025

Volume	3
Average Volume	16
Open	1,120.25
Previous Close	1,124.70
Day's Range	1,116.03 - 1,131.11
52-Week Range	797.74 - 1,236.19
Beta	0.41
RSI	54.45
Earnings Date	Feb 4, 2026

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1833
• Employees: 45,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: M1CK34

Financial Performance

In 2024, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.

Financial numbers in USD